Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.62394342 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.62394342 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.41265552 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.41265552 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.98575358 |
6 | cellular ketone body metabolic process (GO:0046950) | 5.89142937 |
7 | sulfur amino acid catabolic process (GO:0000098) | 5.87003406 |
8 | glyoxylate metabolic process (GO:0046487) | 5.49541465 |
9 | epoxygenase P450 pathway (GO:0019373) | 5.47763420 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.47389101 |
11 | kynurenine metabolic process (GO:0070189) | 5.47226623 |
12 | tryptophan catabolic process (GO:0006569) | 5.40927722 |
13 | indole-containing compound catabolic process (GO:0042436) | 5.40927722 |
14 | indolalkylamine catabolic process (GO:0046218) | 5.40927722 |
15 | cysteine metabolic process (GO:0006534) | 5.29117308 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.29007292 |
17 | lysine catabolic process (GO:0006554) | 5.22683015 |
18 | lysine metabolic process (GO:0006553) | 5.22683015 |
19 | negative regulation of sterol transport (GO:0032372) | 5.13912672 |
20 | negative regulation of cholesterol transport (GO:0032375) | 5.13912672 |
21 | ketone body metabolic process (GO:1902224) | 5.11521212 |
22 | tryptophan metabolic process (GO:0006568) | 5.08776822 |
23 | bile acid biosynthetic process (GO:0006699) | 5.07931351 |
24 | urea cycle (GO:0000050) | 4.81612054 |
25 | urea metabolic process (GO:0019627) | 4.81612054 |
26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.76880834 |
27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71650022 |
28 | negative regulation of fibrinolysis (GO:0051918) | 4.69516114 |
29 | serine family amino acid catabolic process (GO:0009071) | 4.69229769 |
30 | drug metabolic process (GO:0017144) | 4.63729784 |
31 | proline metabolic process (GO:0006560) | 4.49448954 |
32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.49211967 |
33 | protein carboxylation (GO:0018214) | 4.49211967 |
34 | complement activation, alternative pathway (GO:0006957) | 4.48659850 |
35 | homocysteine metabolic process (GO:0050667) | 4.44984846 |
36 | nitrogen cycle metabolic process (GO:0071941) | 4.41537685 |
37 | bile acid metabolic process (GO:0008206) | 4.39570213 |
38 | ethanol oxidation (GO:0006069) | 4.39251231 |
39 | amino-acid betaine metabolic process (GO:0006577) | 4.38532336 |
40 | regulation of fibrinolysis (GO:0051917) | 4.37971911 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 4.34901391 |
42 | regulation of protein activation cascade (GO:2000257) | 4.32038652 |
43 | aromatic amino acid family metabolic process (GO:0009072) | 4.30042385 |
44 | flavonoid metabolic process (GO:0009812) | 4.29679955 |
45 | alpha-amino acid catabolic process (GO:1901606) | 4.25885639 |
46 | cellular glucuronidation (GO:0052695) | 4.25269043 |
47 | regulation of cholesterol homeostasis (GO:2000188) | 4.24674125 |
48 | reverse cholesterol transport (GO:0043691) | 4.20134617 |
49 | bile acid and bile salt transport (GO:0015721) | 4.15175284 |
50 | short-chain fatty acid metabolic process (GO:0046459) | 4.11252593 |
51 | phospholipid efflux (GO:0033700) | 4.11185786 |
52 | cellular amino acid catabolic process (GO:0009063) | 4.08172667 |
53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.07562346 |
54 | protein-lipid complex remodeling (GO:0034368) | 4.07562346 |
55 | macromolecular complex remodeling (GO:0034367) | 4.07562346 |
56 | tyrosine metabolic process (GO:0006570) | 4.05745844 |
57 | regulation of complement activation (GO:0030449) | 4.04442345 |
58 | glutamate metabolic process (GO:0006536) | 4.03734676 |
59 | cellular modified amino acid catabolic process (GO:0042219) | 3.99430154 |
60 | triglyceride homeostasis (GO:0070328) | 3.98677306 |
61 | acylglycerol homeostasis (GO:0055090) | 3.98677306 |
62 | drug catabolic process (GO:0042737) | 3.98433727 |
63 | regulation of cholesterol esterification (GO:0010872) | 3.97198039 |
64 | blood coagulation, intrinsic pathway (GO:0007597) | 3.95345790 |
65 | oxidative demethylation (GO:0070989) | 3.89178986 |
66 | serine family amino acid metabolic process (GO:0009069) | 3.88065749 |
67 | alkaloid metabolic process (GO:0009820) | 3.87067859 |
68 | plasma lipoprotein particle clearance (GO:0034381) | 3.85571143 |
69 | coenzyme catabolic process (GO:0009109) | 3.85277543 |
70 | benzene-containing compound metabolic process (GO:0042537) | 3.83385970 |
71 | plasma lipoprotein particle assembly (GO:0034377) | 3.81482091 |
72 | aspartate family amino acid catabolic process (GO:0009068) | 3.81115428 |
73 | glycine metabolic process (GO:0006544) | 3.80709543 |
74 | 2-oxoglutarate metabolic process (GO:0006103) | 3.79791730 |
75 | proline biosynthetic process (GO:0006561) | 3.79733229 |
76 | acetyl-CoA metabolic process (GO:0006084) | 3.79638937 |
77 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79342494 |
78 | uronic acid metabolic process (GO:0006063) | 3.78391452 |
79 | glucuronate metabolic process (GO:0019585) | 3.78391452 |
80 | NADH metabolic process (GO:0006734) | 3.77915988 |
81 | omega-hydroxylase P450 pathway (GO:0097267) | 3.76234164 |
82 | fatty acid beta-oxidation (GO:0006635) | 3.74674111 |
83 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73930488 |
84 | indolalkylamine metabolic process (GO:0006586) | 3.72560174 |
85 | fatty acid oxidation (GO:0019395) | 3.71850140 |
86 | phospholipid homeostasis (GO:0055091) | 3.70341875 |
87 | lipid oxidation (GO:0034440) | 3.64636832 |
88 | organic acid catabolic process (GO:0016054) | 3.64523821 |
89 | carboxylic acid catabolic process (GO:0046395) | 3.64523821 |
90 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.62992405 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 3.62972128 |
92 | arginine catabolic process (GO:0006527) | 3.62389736 |
93 | drug transmembrane transport (GO:0006855) | 3.60400868 |
94 | intestinal absorption (GO:0050892) | 3.59832146 |
95 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.59804246 |
96 | exogenous drug catabolic process (GO:0042738) | 3.59044735 |
97 | cellular biogenic amine catabolic process (GO:0042402) | 3.56276409 |
98 | amine catabolic process (GO:0009310) | 3.56276409 |
99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53992704 |
100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53992704 |
101 | cholesterol homeostasis (GO:0042632) | 3.53887774 |
102 | monocarboxylic acid catabolic process (GO:0072329) | 3.53623441 |
103 | fatty acid catabolic process (GO:0009062) | 3.51197204 |
104 | protein-lipid complex assembly (GO:0065005) | 3.50624944 |
105 | sterol homeostasis (GO:0055092) | 3.50514976 |
106 | arginine metabolic process (GO:0006525) | 3.48538081 |
107 | urate metabolic process (GO:0046415) | 3.47937320 |
108 | cholesterol efflux (GO:0033344) | 3.47822767 |
109 | ethanol metabolic process (GO:0006067) | 3.47066620 |
110 | imidazole-containing compound metabolic process (GO:0052803) | 3.46173463 |
111 | positive regulation of lipid catabolic process (GO:0050996) | 3.45030375 |
112 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.42390948 |
113 | low-density lipoprotein particle remodeling (GO:0034374) | 3.42174588 |
114 | carnitine metabolic process (GO:0009437) | 3.40894097 |
115 | phosphate ion transmembrane transport (GO:0035435) | 3.40601629 |
116 | plasma lipoprotein particle organization (GO:0071827) | 3.38929931 |
117 | phenylpropanoid metabolic process (GO:0009698) | 3.36906646 |
118 | quinone biosynthetic process (GO:1901663) | 3.32720372 |
119 | diacylglycerol metabolic process (GO:0046339) | 3.31966742 |
120 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.28255958 |
121 | regulation of plasminogen activation (GO:0010755) | 3.27114722 |
122 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.19334867 |
123 | fibrinolysis (GO:0042730) | 3.11812942 |
124 | protein-lipid complex subunit organization (GO:0071825) | 3.09506844 |
125 | quinone metabolic process (GO:1901661) | 3.09481098 |
126 | regulation of lipoprotein particle clearance (GO:0010984) | 3.08202581 |
127 | daunorubicin metabolic process (GO:0044597) | 3.07273703 |
128 | polyketide metabolic process (GO:0030638) | 3.07273703 |
129 | doxorubicin metabolic process (GO:0044598) | 3.07273703 |
130 | protein activation cascade (GO:0072376) | 3.07131442 |
131 | regulation of bile acid biosynthetic process (GO:0070857) | 3.00143834 |
132 | intestinal cholesterol absorption (GO:0030299) | 2.99539222 |
133 | oxaloacetate metabolic process (GO:0006107) | 2.98747739 |
134 | negative regulation of blood coagulation (GO:0030195) | 2.98341138 |
135 | negative regulation of hemostasis (GO:1900047) | 2.98341138 |
136 | cofactor catabolic process (GO:0051187) | 2.98112677 |
137 | complement activation, classical pathway (GO:0006958) | 2.97245887 |
138 | L-ascorbic acid metabolic process (GO:0019852) | 2.92340912 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.25899689 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.46875505 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.89351598 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.53968143 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.21868645 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.53772028 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08719597 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.39836307 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.88853936 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.76539534 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.51024445 |
12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.18173323 |
13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.16717043 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2752497 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98466457 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96196500 |
17 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91344377 |
18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.84489185 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73516000 |
20 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.73152124 |
21 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.71227777 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70827843 |
23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70462507 |
24 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.68162009 |
25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.65429043 |
26 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.64367089 |
27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.58828404 |
28 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56898053 |
29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.52728385 |
30 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.51637054 |
31 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.50108693 |
32 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.48952752 |
33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46563498 |
34 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.46513782 |
35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44605322 |
36 | SA1_27219007_Chip-Seq_Bcells_Human | 1.44172629 |
37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44068898 |
38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41774990 |
39 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.38761811 |
40 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37864325 |
41 | ERA_21632823_ChIP-Seq_H3396_Human | 1.36494877 |
42 | P300_27268052_Chip-Seq_Bcells_Human | 1.35849158 |
43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34876639 |
44 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.34631452 |
45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.34545053 |
46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34210253 |
47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33376114 |
48 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32512447 |
49 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.31826401 |
50 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.31165210 |
51 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29161779 |
52 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26929390 |
53 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.23016959 |
54 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.22177157 |
55 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.18442629 |
56 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.18420683 |
57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17170807 |
58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16762793 |
59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15519978 |
60 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15480199 |
61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14761723 |
62 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.13699271 |
63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13160971 |
64 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.11828303 |
65 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09571472 |
66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09334397 |
67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09065876 |
68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08963903 |
69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07531498 |
70 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07508325 |
71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07057618 |
72 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07027714 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05202998 |
74 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04911998 |
75 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04707011 |
76 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03774177 |
77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03427064 |
78 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02471702 |
79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02341068 |
80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02160791 |
81 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01726521 |
82 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01684339 |
83 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01519392 |
84 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01370296 |
85 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01083351 |
86 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.99540366 |
87 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99529732 |
88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99058931 |
89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96960439 |
90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95996482 |
91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95888419 |
92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95326768 |
93 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.94461563 |
94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94197145 |
95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92938614 |
96 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91233812 |
97 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90589027 |
98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88658239 |
99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86550264 |
100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86000010 |
101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85117648 |
102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84301097 |
103 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83016189 |
104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82333708 |
105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82041912 |
106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81236071 |
107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81023896 |
108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80280760 |
109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80051186 |
110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79886482 |
111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77592531 |
112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77056634 |
113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76524788 |
114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76288303 |
115 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.75643016 |
116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73529757 |
117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73351865 |
118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73118951 |
119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72680933 |
120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71874331 |
121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71702949 |
122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.70932041 |
123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70014940 |
124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69362582 |
125 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68400525 |
126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68033282 |
127 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.67826558 |
128 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.67341807 |
129 | P68_20966046_ChIP-Seq_HELA_Human | 0.66741247 |
130 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.66038963 |
131 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65896288 |
132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.65743434 |
133 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.65532865 |
134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65095543 |
135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.65060727 |
136 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64067704 |
137 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.63977207 |
138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.63701458 |
139 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.62095654 |
140 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62044782 |
141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.61862772 |
142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61327393 |
143 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.61312037 |
144 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61219715 |
145 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.61108582 |
146 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60387569 |
147 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.59993018 |
148 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59943918 |
149 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.58192510 |
150 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58086762 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.41374987 |
2 | MP0005360_urolithiasis | 6.92680233 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.37305672 |
4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.23097663 |
5 | MP0005365_abnormal_bile_salt | 5.08079473 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.55376979 |
7 | MP0002822_catalepsy | 3.50823172 |
8 | MP0003252_abnormal_bile_duct | 3.22760117 |
9 | MP0010329_abnormal_lipoprotein_level | 3.22214434 |
10 | MP0009840_abnormal_foam_cell | 3.09644316 |
11 | MP0003191_abnormal_cellular_cholesterol | 3.01719226 |
12 | MP0005083_abnormal_biliary_tract | 2.91454711 |
13 | MP0003283_abnormal_digestive_organ | 2.85151954 |
14 | MP0001666_abnormal_nutrient_absorption | 2.62085195 |
15 | MP0005332_abnormal_amino_acid | 2.53023984 |
16 | MP0003195_calcinosis | 2.27136969 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.24745194 |
18 | MP0003878_abnormal_ear_physiology | 2.02437960 |
19 | MP0005377_hearing/vestibular/ear_phenot | 2.02437960 |
20 | MP0000609_abnormal_liver_physiology | 2.02010845 |
21 | MP0002118_abnormal_lipid_homeostasis | 2.00315635 |
22 | MP0003705_abnormal_hypodermis_morpholog | 1.99943762 |
23 | MP0002138_abnormal_hepatobiliary_system | 1.97569386 |
24 | MP0005167_abnormal_blood-brain_barrier | 1.70765804 |
25 | MP0000566_synostosis | 1.68804642 |
26 | MP0005319_abnormal_enzyme/_coenzyme | 1.67817742 |
27 | MP0009379_abnormal_foot_pigmentation | 1.65373758 |
28 | MP0003656_abnormal_erythrocyte_physiolo | 1.60765778 |
29 | MP0009643_abnormal_urine_homeostasis | 1.56648548 |
30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55814600 |
31 | MP0003868_abnormal_feces_composition | 1.51791867 |
32 | MP0003718_maternal_effect | 1.45563402 |
33 | MP0008872_abnormal_physiological_respon | 1.37644375 |
34 | MP0000678_abnormal_parathyroid_gland | 1.35689634 |
35 | MP0005451_abnormal_body_composition | 1.25071174 |
36 | MP0005636_abnormal_mineral_homeostasis | 1.22322111 |
37 | MP0003186_abnormal_redox_activity | 1.20197841 |
38 | MP0004130_abnormal_muscle_cell | 1.15995918 |
39 | MP0005670_abnormal_white_adipose | 1.15734044 |
40 | MP0010234_abnormal_vibrissa_follicle | 1.15299949 |
41 | MP0002132_abnormal_respiratory_system | 1.14822002 |
42 | MP0002249_abnormal_larynx_morphology | 1.13134859 |
43 | MP0001764_abnormal_homeostasis | 1.07445124 |
44 | MP0000598_abnormal_liver_morphology | 1.07104545 |
45 | MP0002653_abnormal_ependyma_morphology | 1.03186235 |
46 | MP0004858_abnormal_nervous_system | 1.00451306 |
47 | MP0001664_abnormal_digestion | 0.99510374 |
48 | MP0000538_abnormal_urinary_bladder | 0.98459094 |
49 | MP0001873_stomach_inflammation | 0.95251128 |
50 | MP0003646_muscle_fatigue | 0.94877427 |
51 | MP0000604_amyloidosis | 0.93250542 |
52 | MP0009384_cardiac_valve_regurgitation | 0.93028288 |
53 | MP0009333_abnormal_splenocyte_physiolog | 0.90421376 |
54 | MP0002254_reproductive_system_inflammat | 0.88550123 |
55 | MP0004043_abnormal_pH_regulation | 0.87537010 |
56 | MP0005666_abnormal_adipose_tissue | 0.87140083 |
57 | MP0002089_abnormal_postnatal_growth/wei | 0.86831600 |
58 | MP0001756_abnormal_urination | 0.86248419 |
59 | MP0005647_abnormal_sex_gland | 0.85364899 |
60 | MP0006036_abnormal_mitochondrial_physio | 0.85064755 |
61 | MP0005645_abnormal_hypothalamus_physiol | 0.83602343 |
62 | MP0005397_hematopoietic_system_phenotyp | 0.82227424 |
63 | MP0001545_abnormal_hematopoietic_system | 0.82227424 |
64 | MP0003300_gastrointestinal_ulcer | 0.81503311 |
65 | MP0000467_abnormal_esophagus_morphology | 0.77407699 |
66 | MP0009642_abnormal_blood_homeostasis | 0.77202167 |
67 | MP0003693_abnormal_embryo_hatching | 0.76972365 |
68 | MP0009763_increased_sensitivity_to | 0.74925255 |
69 | MP0002971_abnormal_brown_adipose | 0.74267571 |
70 | MP0009764_decreased_sensitivity_to | 0.73763713 |
71 | MP0003329_amyloid_beta_deposits | 0.73368620 |
72 | MP0004185_abnormal_adipocyte_glucose | 0.71942129 |
73 | MP0002837_dystrophic_cardiac_calcinosis | 0.71110632 |
74 | MP0002796_impaired_skin_barrier | 0.70835995 |
75 | MP0008469_abnormal_protein_level | 0.70755847 |
76 | MP0000462_abnormal_digestive_system | 0.70492355 |
77 | MP0003011_delayed_dark_adaptation | 0.70127776 |
78 | MP0001765_abnormal_ion_homeostasis | 0.69598320 |
79 | MP0002078_abnormal_glucose_homeostasis | 0.69127704 |
80 | MP0002136_abnormal_kidney_physiology | 0.67967344 |
81 | MP0005334_abnormal_fat_pad | 0.66745867 |
82 | MP0000003_abnormal_adipose_tissue | 0.66592303 |
83 | MP0003879_abnormal_hair_cell | 0.65956238 |
84 | MP0010155_abnormal_intestine_physiology | 0.64677405 |
85 | MP0002098_abnormal_vibrissa_morphology | 0.64276078 |
86 | MP0003075_altered_response_to | 0.63659079 |
87 | MP0003183_abnormal_peptide_metabolism | 0.61806544 |
88 | MP0008873_increased_physiological_sensi | 0.58471462 |
89 | MP0003866_abnormal_defecation | 0.58371797 |
90 | MP0009765_abnormal_xenobiotic_induced | 0.58220451 |
91 | MP0002938_white_spotting | 0.57297590 |
92 | MP0001727_abnormal_embryo_implantation | 0.57268867 |
93 | MP0003690_abnormal_glial_cell | 0.56641146 |
94 | MP0005376_homeostasis/metabolism_phenot | 0.56572788 |
95 | MP0000490_abnormal_crypts_of | 0.56075393 |
96 | MP0005266_abnormal_metabolism | 0.54985795 |
97 | MP0005395_other_phenotype | 0.54654929 |
98 | MP0005058_abnormal_lysosome_morphology | 0.53856116 |
99 | MP0005220_abnormal_exocrine_pancreas | 0.52988891 |
100 | MP0005084_abnormal_gallbladder_morpholo | 0.52952392 |
101 | MP0005166_decreased_susceptibility_to | 0.52350206 |
102 | MP0000681_abnormal_thyroid_gland | 0.52191133 |
103 | MP0005535_abnormal_body_temperature | 0.51339623 |
104 | MP0001661_extended_life_span | 0.51188971 |
105 | MP0002909_abnormal_adrenal_gland | 0.51038045 |
106 | MP0009053_abnormal_anal_canal | 0.50296867 |
107 | MP0010368_abnormal_lymphatic_system | 0.49999353 |
108 | MP0000013_abnormal_adipose_tissue | 0.49938724 |
109 | MP0005448_abnormal_energy_balance | 0.48273118 |
110 | MP0004264_abnormal_extraembryonic_tissu | 0.46080936 |
111 | MP0005375_adipose_tissue_phenotype | 0.44192469 |
112 | MP0005381_digestive/alimentary_phenotyp | 0.43919332 |
113 | MP0004147_increased_porphyrin_level | 0.43687863 |
114 | MP0006035_abnormal_mitochondrial_morpho | 0.43346274 |
115 | MP0009115_abnormal_fat_cell | 0.42050624 |
116 | MP0002269_muscular_atrophy | 0.41195016 |
117 | MP0000230_abnormal_systemic_arterial | 0.40804818 |
118 | MP0004947_skin_inflammation | 0.40773439 |
119 | MP0009672_abnormal_birth_weight | 0.40197687 |
120 | MP0005464_abnormal_platelet_physiology | 0.38991101 |
121 | MP0002060_abnormal_skin_morphology | 0.38538262 |
122 | MP0003638_abnormal_response/metabolism_ | 0.38515157 |
123 | MP0003953_abnormal_hormone_level | 0.38089980 |
124 | MP0008961_abnormal_basal_metabolism | 0.37956960 |
125 | MP0000249_abnormal_blood_vessel | 0.37854148 |
126 | MP0009697_abnormal_copulation | 0.37368867 |
127 | MP0001663_abnormal_digestive_system | 0.36702971 |
128 | MP0008874_decreased_physiological_sensi | 0.36116213 |
129 | MP0000477_abnormal_intestine_morphology | 0.36083907 |
130 | MP0004782_abnormal_surfactant_physiolog | 0.35567119 |
131 | MP0002876_abnormal_thyroid_physiology | 0.34989493 |
132 | MP0002970_abnormal_white_adipose | 0.33155330 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.19856586 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.11123220 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.04726586 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.64001112 |
5 | Xanthomatosis (HP:0000991) | 5.53026636 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.11472074 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 4.78106768 |
8 | Hyperammonemia (HP:0001987) | 4.54355046 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.51876405 |
10 | Complement deficiency (HP:0004431) | 4.36296571 |
11 | Hypolipoproteinemia (HP:0010981) | 4.19998497 |
12 | Ketosis (HP:0001946) | 4.18039551 |
13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12225811 |
14 | Hyperglycinuria (HP:0003108) | 4.04943940 |
15 | Hypoalphalipoproteinemia (HP:0003233) | 3.99481824 |
16 | Cerebral palsy (HP:0100021) | 3.91318768 |
17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.89610397 |
18 | Abnormality of glycine metabolism (HP:0010895) | 3.85449090 |
19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85449090 |
20 | Hyperglycinemia (HP:0002154) | 3.82456094 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.77524645 |
22 | Joint hemorrhage (HP:0005261) | 3.64860086 |
23 | Hypoglycemic coma (HP:0001325) | 3.64623538 |
24 | Epidermoid cyst (HP:0200040) | 3.64263938 |
25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.58623223 |
26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.52709718 |
27 | Gout (HP:0001997) | 3.52041563 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.46438797 |
29 | Fat malabsorption (HP:0002630) | 3.36870182 |
30 | Abnormality of complement system (HP:0005339) | 3.32619743 |
31 | Ketoacidosis (HP:0001993) | 3.24666332 |
32 | Abnormality of methionine metabolism (HP:0010901) | 3.21916681 |
33 | Abnormality of purine metabolism (HP:0004352) | 3.20299652 |
34 | Hyperbilirubinemia (HP:0002904) | 3.15135676 |
35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.14693709 |
36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07502343 |
37 | Dicarboxylic aciduria (HP:0003215) | 2.96702959 |
38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96702959 |
39 | Hypercholesterolemia (HP:0003124) | 2.86862462 |
40 | Metabolic acidosis (HP:0001942) | 2.86712903 |
41 | Abnormality of the intrinsic pathway (HP:0010989) | 2.85023455 |
42 | Hepatic necrosis (HP:0002605) | 2.84201082 |
43 | Abnormality of urine glucose concentration (HP:0011016) | 2.83973947 |
44 | Glycosuria (HP:0003076) | 2.83973947 |
45 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.81907726 |
46 | Ileus (HP:0002595) | 2.80335276 |
47 | Hepatocellular carcinoma (HP:0001402) | 2.77795612 |
48 | Abnormal cartilage morphology (HP:0002763) | 2.75146096 |
49 | Cholelithiasis (HP:0001081) | 2.74760979 |
50 | Glomerulonephritis (HP:0000099) | 2.73833072 |
51 | Myocardial infarction (HP:0001658) | 2.72767272 |
52 | Abnormal gallbladder morphology (HP:0012437) | 2.64533872 |
53 | Acanthocytosis (HP:0001927) | 2.60315739 |
54 | Lethargy (HP:0001254) | 2.57694984 |
55 | Increased purine levels (HP:0004368) | 2.57530880 |
56 | Hyperuricemia (HP:0002149) | 2.57530880 |
57 | Delayed CNS myelination (HP:0002188) | 2.56802944 |
58 | Sensorimotor neuropathy (HP:0007141) | 2.55986631 |
59 | Nausea (HP:0002018) | 2.53667085 |
60 | Hepatocellular necrosis (HP:0001404) | 2.52444997 |
61 | Neonatal onset (HP:0003623) | 2.50905581 |
62 | Abnormality of serum amino acid levels (HP:0003112) | 2.50575844 |
63 | Increased serum ferritin (HP:0003281) | 2.49668483 |
64 | Steatorrhea (HP:0002570) | 2.49643935 |
65 | Spastic diplegia (HP:0001264) | 2.48975396 |
66 | Acute encephalopathy (HP:0006846) | 2.48921346 |
67 | Late onset (HP:0003584) | 2.48061050 |
68 | Increased muscle lipid content (HP:0009058) | 2.47112587 |
69 | Conjugated hyperbilirubinemia (HP:0002908) | 2.45552928 |
70 | Hypochromic microcytic anemia (HP:0004840) | 2.42877001 |
71 | Poikilocytosis (HP:0004447) | 2.39112857 |
72 | Cupped ribs (HP:0000887) | 2.38946050 |
73 | Abnormal gallbladder physiology (HP:0012438) | 2.38130970 |
74 | Cholecystitis (HP:0001082) | 2.38130970 |
75 | Malnutrition (HP:0004395) | 2.37072851 |
76 | Esophageal varix (HP:0002040) | 2.34876394 |
77 | Abnormal number of erythroid precursors (HP:0012131) | 2.33993295 |
78 | Vascular calcification (HP:0004934) | 2.33056117 |
79 | Abnormality of alanine metabolism (HP:0010916) | 2.28804112 |
80 | Hyperalaninemia (HP:0003348) | 2.28804112 |
81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28804112 |
82 | Skin nodule (HP:0200036) | 2.21804640 |
83 | Spontaneous abortion (HP:0005268) | 2.19876848 |
84 | Purpura (HP:0000979) | 2.19745362 |
85 | Cerebral edema (HP:0002181) | 2.19032493 |
86 | Vomiting (HP:0002013) | 2.18291006 |
87 | Nephrolithiasis (HP:0000787) | 2.16559678 |
88 | Reticulocytosis (HP:0001923) | 2.16524523 |
89 | Abnormality of the gallbladder (HP:0005264) | 2.15017576 |
90 | Flat acetabular roof (HP:0003180) | 2.14756919 |
91 | Polycythemia (HP:0001901) | 2.14333909 |
92 | Widely patent fontanelles and sutures (HP:0004492) | 2.13761685 |
93 | Petechiae (HP:0000967) | 2.12867493 |
94 | Abnormality of proline metabolism (HP:0010907) | 2.11506985 |
95 | Hydroxyprolinuria (HP:0003080) | 2.11506985 |
96 | Irritability (HP:0000737) | 2.10779686 |
97 | Stridor (HP:0010307) | 2.08711012 |
98 | Generalized aminoaciduria (HP:0002909) | 2.08290695 |
99 | Cardiovascular calcification (HP:0011915) | 2.07933383 |
100 | Alkalosis (HP:0001948) | 2.07260434 |
101 | Lactic acidosis (HP:0003128) | 2.06683544 |
102 | Systemic lupus erythematosus (HP:0002725) | 2.06614579 |
103 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.05684660 |
104 | Nephritis (HP:0000123) | 2.05364933 |
105 | Myoglobinuria (HP:0002913) | 2.03422310 |
106 | Mitochondrial inheritance (HP:0001427) | 2.03169490 |
107 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.01795536 |
108 | Pancreatitis (HP:0001733) | 1.99433127 |
109 | Mesangial abnormality (HP:0001966) | 1.99177343 |
110 | Decreased circulating renin level (HP:0003351) | 1.98193194 |
111 | Hypoglycemic seizures (HP:0002173) | 1.97742248 |
112 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97343376 |
113 | Hyperphosphaturia (HP:0003109) | 1.96274822 |
114 | Increased serum lactate (HP:0002151) | 1.95839687 |
115 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95028477 |
116 | Right ventricular cardiomyopathy (HP:0011663) | 1.93759865 |
117 | Menorrhagia (HP:0000132) | 1.93617421 |
118 | Reduced antithrombin III activity (HP:0001976) | 1.93577796 |
119 | Abnormality of iron homeostasis (HP:0011031) | 1.92532034 |
120 | Absent phalangeal crease (HP:0006109) | 1.92208281 |
121 | Rickets (HP:0002748) | 1.91895797 |
122 | Mitral stenosis (HP:0001718) | 1.91410092 |
123 | Increased serum pyruvate (HP:0003542) | 1.90870684 |
124 | Microretrognathia (HP:0000308) | 1.90786271 |
125 | Abnormality of the Achilles tendon (HP:0005109) | 1.90566902 |
126 | Opisthotonus (HP:0002179) | 1.90564497 |
127 | Potter facies (HP:0002009) | 1.90419637 |
128 | Facial shape deformation (HP:0011334) | 1.90419637 |
129 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90346578 |
130 | Abnormality of the 1st metacarpal (HP:0010009) | 1.89365619 |
131 | Enlarged kidneys (HP:0000105) | 1.89018128 |
132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88673462 |
133 | Hypertriglyceridemia (HP:0002155) | 1.84580787 |
134 | Wide cranial sutures (HP:0010537) | 1.83729861 |
135 | Amyloidosis (HP:0011034) | 1.83661152 |
136 | Hemorrhage of the eye (HP:0011885) | 1.83124968 |
137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81132928 |
138 | Proximal tubulopathy (HP:0000114) | 1.79215694 |
139 | Back pain (HP:0003418) | 1.78345971 |
140 | Increased CSF lactate (HP:0002490) | 1.78273561 |
141 | Abnormality of vitamin metabolism (HP:0100508) | 1.77968714 |
142 | Rhabdomyolysis (HP:0003201) | 1.77657447 |
143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76406527 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 6.59254647 |
2 | BCKDK | 5.13872815 |
3 | VRK2 | 4.60181758 |
4 | ERN1 | 3.76339088 |
5 | TRIB3 | 3.34545291 |
6 | PKN2 | 3.33860544 |
7 | PIM2 | 3.33823580 |
8 | SIK1 | 3.05462248 |
9 | PIK3CA | 2.96311462 |
10 | FGFR4 | 2.80769416 |
11 | MET | 2.59517925 |
12 | SMG1 | 2.37374502 |
13 | EPHA2 | 2.31458665 |
14 | ZAK | 2.25627558 |
15 | TESK2 | 2.18330367 |
16 | TLK1 | 2.15199982 |
17 | ACVR1B | 2.06448404 |
18 | MAPKAPK3 | 2.04808913 |
19 | MAP4K2 | 1.81930192 |
20 | PTK6 | 1.75485876 |
21 | ERBB4 | 1.69940886 |
22 | MAP2K2 | 1.63561880 |
23 | NUAK1 | 1.62963852 |
24 | MAP2K4 | 1.59880357 |
25 | MAP3K10 | 1.59049813 |
26 | GRK6 | 1.47911656 |
27 | MAP3K11 | 1.43707089 |
28 | MAPK11 | 1.42154143 |
29 | EEF2K | 1.40369526 |
30 | FLT3 | 1.39390540 |
31 | IRAK3 | 1.39207049 |
32 | VRK1 | 1.38798582 |
33 | TIE1 | 1.38580490 |
34 | EPHB1 | 1.35562976 |
35 | GRK1 | 1.28411580 |
36 | WNK4 | 1.27297682 |
37 | STK16 | 1.26799858 |
38 | TESK1 | 1.23313360 |
39 | MAP3K7 | 1.22262202 |
40 | TAOK3 | 1.19550762 |
41 | MUSK | 1.18348474 |
42 | NME1 | 1.14099643 |
43 | BUB1 | 1.12529280 |
44 | TTN | 1.12497561 |
45 | NEK1 | 1.11365638 |
46 | ICK | 1.10764867 |
47 | ADRBK2 | 1.10212545 |
48 | ILK | 1.09448547 |
49 | RIPK1 | 1.06445344 |
50 | CAMK1D | 0.95495104 |
51 | KSR2 | 0.95048892 |
52 | JAK2 | 0.94424802 |
53 | CSNK1G3 | 0.90386940 |
54 | MAPKAPK5 | 0.90153726 |
55 | DYRK2 | 0.90007700 |
56 | MAP2K1 | 0.89311504 |
57 | PIK3CG | 0.89216286 |
58 | TYK2 | 0.88910286 |
59 | FRK | 0.86307286 |
60 | CDK8 | 0.85102384 |
61 | RPS6KA5 | 0.83014069 |
62 | TBK1 | 0.82883584 |
63 | DAPK1 | 0.82287488 |
64 | MAP2K3 | 0.81492557 |
65 | LMTK2 | 0.80761694 |
66 | PDPK1 | 0.80081798 |
67 | DAPK2 | 0.79639366 |
68 | CSK | 0.78787960 |
69 | EPHB2 | 0.77829885 |
70 | LRRK2 | 0.77581286 |
71 | DYRK1B | 0.76182111 |
72 | CDK6 | 0.75275921 |
73 | LATS1 | 0.75263641 |
74 | PRKAA2 | 0.72901811 |
75 | INSRR | 0.72557676 |
76 | BMPR1B | 0.72463002 |
77 | BMX | 0.72067656 |
78 | AURKA | 0.71331681 |
79 | RPS6KA6 | 0.69283421 |
80 | ABL2 | 0.68760034 |
81 | MAP3K1 | 0.68759452 |
82 | FGFR2 | 0.68354413 |
83 | CHEK2 | 0.67857567 |
84 | ERBB2 | 0.67745527 |
85 | CDK19 | 0.66238138 |
86 | RET | 0.64724281 |
87 | CSNK1A1L | 0.64401466 |
88 | NME2 | 0.63862921 |
89 | PDGFRA | 0.63611169 |
90 | NEK9 | 0.63507398 |
91 | PTK2 | 0.63413839 |
92 | IKBKB | 0.62443860 |
93 | MAP3K12 | 0.61999663 |
94 | DAPK3 | 0.61361186 |
95 | PDK1 | 0.61201236 |
96 | MAP2K6 | 0.59749600 |
97 | TAOK2 | 0.58845855 |
98 | MAPK12 | 0.58401912 |
99 | MAP3K2 | 0.58003761 |
100 | TAOK1 | 0.57966486 |
101 | PRKCI | 0.57918813 |
102 | CDK9 | 0.57791253 |
103 | PDK3 | 0.57658123 |
104 | PDK4 | 0.57658123 |
105 | PRKAA1 | 0.57138804 |
106 | MYLK | 0.56673812 |
107 | PAK4 | 0.55854666 |
108 | KDR | 0.55246508 |
109 | GSK3A | 0.55076779 |
110 | RPS6KC1 | 0.54841717 |
111 | RPS6KL1 | 0.54841717 |
112 | MAP3K8 | 0.52677180 |
113 | TGFBR2 | 0.52549544 |
114 | ARAF | 0.52141286 |
115 | JAK1 | 0.51449749 |
116 | MAPK4 | 0.50727540 |
117 | CDK7 | 0.50639941 |
118 | LIMK1 | 0.49908191 |
119 | MTOR | 0.48467246 |
120 | PRKACG | 0.48436258 |
121 | PHKG1 | 0.48323288 |
122 | PHKG2 | 0.48323288 |
123 | CDK4 | 0.47048622 |
124 | CSNK1G1 | 0.45485015 |
125 | KIT | 0.44441194 |
126 | DDR2 | 0.44242058 |
127 | MAP3K3 | 0.42452035 |
128 | CAMK1G | 0.42385926 |
129 | PRKCZ | 0.42378253 |
130 | RPS6KA2 | 0.42110229 |
131 | CAMK2G | 0.41350387 |
132 | MAP3K4 | 0.41172534 |
133 | PRKCH | 0.40930561 |
134 | MATK | 0.40641716 |
135 | SGK3 | 0.40406907 |
136 | CSNK2A1 | 0.40250001 |
137 | FGFR3 | 0.40055473 |
138 | TNK2 | 0.39606708 |
139 | PRKG2 | 0.39149833 |
140 | ADRBK1 | 0.37966514 |
141 | MAP4K1 | 0.36915885 |
142 | STK39 | 0.36835651 |
143 | PRKCA | 0.35474283 |
144 | CSNK1G2 | 0.34119805 |
145 | BRAF | 0.33531987 |
146 | MAPKAPK2 | 0.33337804 |
147 | PIM1 | 0.32956147 |
148 | RPS6KB2 | 0.32653723 |
149 | CSNK1A1 | 0.32142520 |
150 | PINK1 | 0.31977835 |
151 | EPHA4 | 0.31800760 |
152 | WNK3 | 0.31185053 |
153 | NEK2 | 0.31041161 |
154 | EPHA3 | 0.30560111 |
155 | CAMK2D | 0.27676553 |
156 | STK10 | 0.27515855 |
157 | AKT2 | 0.27292673 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.83198385 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38245267 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33466707 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12157941 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.77296115 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.77276809 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76985028 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68839194 |
9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.66784093 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60946146 |
11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.51089125 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.36305060 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32638809 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26302813 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.15421606 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10633276 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06481716 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03363495 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00582709 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99535618 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.93907102 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90446597 |
23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82732447 |
24 | * Sulfur metabolism_Homo sapiens_hsa00920 | 1.77232569 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77145929 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66154003 |
27 | Bile secretion_Homo sapiens_hsa04976 | 1.65598917 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61508085 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53943315 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53742041 |
31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50101723 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44866910 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44546917 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42185854 |
35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41593878 |
36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39717073 |
37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37624203 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34076958 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28857363 |
40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28478397 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26687960 |
42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23048778 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21770623 |
44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.18864934 |
45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15862080 |
46 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13501601 |
47 | ABC transporters_Homo sapiens_hsa02010 | 1.10695518 |
48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09641400 |
49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05560749 |
50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03569879 |
51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02883770 |
52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00049445 |
53 | * Sulfur relay system_Homo sapiens_hsa04122 | 0.97158878 |
54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96497264 |
55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93902194 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93103293 |
57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86751178 |
58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85410302 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.84254343 |
60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80198984 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79273941 |
62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75781374 |
63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75341140 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74240469 |
65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69427901 |
66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68968895 |
67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67476434 |
68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62288601 |
69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61011312 |
70 | Base excision repair_Homo sapiens_hsa03410 | 0.59705755 |
71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54298924 |
72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54156041 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52311952 |
74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49902165 |
75 | Ribosome_Homo sapiens_hsa03010 | 0.47071494 |
76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47012098 |
77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46605248 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46506387 |
79 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44237158 |
80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39159288 |
81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38568217 |
82 | Insulin resistance_Homo sapiens_hsa04931 | 0.36444733 |
83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35542569 |
84 | Prion diseases_Homo sapiens_hsa05020 | 0.35189987 |
85 | Proteasome_Homo sapiens_hsa03050 | 0.33534318 |
86 | DNA replication_Homo sapiens_hsa03030 | 0.32786118 |
87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28671638 |
88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27204085 |
89 | Mineral absorption_Homo sapiens_hsa04978 | 0.25569074 |
90 | RNA polymerase_Homo sapiens_hsa03020 | 0.22077619 |
91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21903046 |
92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21560681 |
93 | Homologous recombination_Homo sapiens_hsa03440 | 0.21503655 |
94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20585404 |
95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19895507 |
96 | Purine metabolism_Homo sapiens_hsa00230 | 0.18925363 |
97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15908718 |
98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13252215 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12747965 |
100 | Bladder cancer_Homo sapiens_hsa05219 | 0.12579945 |
101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09803565 |
102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.07564263 |
103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05649252 |
104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.05249339 |
105 | Amoebiasis_Homo sapiens_hsa05146 | -0.1572178 |
106 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1569286 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1536090 |
108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1462263 |
109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1450754 |
110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1432533 |
111 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1331422 |
112 | Hepatitis C_Homo sapiens_hsa05160 | -0.1155799 |
113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1128712 |
114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1124979 |
115 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1103983 |
116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0735361 |
117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0652076 |